Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/1998
03/25/1998CN1177379A Prodn. of gamma linolenic acid by a
03/25/1998CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof
03/25/1998CN1177302A Lymphotoxin-
03/25/1998CA2216439A1 Pharmaceuticals containing retinal stem cells
03/25/1998CA2216203A1 Method of thawing cryopreserved cells
03/24/1998US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
03/24/1998US5731417 Cell culture substrates and method of making
03/24/1998US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides
03/24/1998US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
03/24/1998US5731202 Methods of regeneration of Medicago sativa and expressing foreign DNA in same
03/24/1998US5731201 Method for producing virus-free rootsticks of hop
03/24/1998US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein
03/24/1998US5731195 Specified amino acid sequences
03/24/1998US5731193 Plasmid vector and an interferon promoter increasing produce gene expressed polypeptide
03/24/1998US5731183 Bacillus-derived transglutaminase
03/24/1998US5731181 Chimeric mutational vectors having non-natural nucleotides
03/24/1998US5731180 Imidazolinone resistant AHAS mutants
03/24/1998US5731170 DNA encoding a growth factor specific for epithelial cells
03/24/1998US5731168 Method for making heteromultimeric polypeptides
03/24/1998US5731160 Induction of antigen specific T-lymphocyte responses by stimulation with peptide loaded MHC class I molecules on antigen processing defective mammalian cell lines
03/24/1998US5731154 Method for detecting human contactin
03/24/1998US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof
03/24/1998US5730981 Monoclonal anti-ganglioside antibody and its preparation
03/24/1998US5730977 Anti-VEGF human monoclonal antibody
03/24/1998US5730974 Reversing opiate tolerance by cellular implantation
03/24/1998CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy
03/24/1998CA1339776C Equine-gamma-interferon
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011235A2 Transgenic plants expressing cellulolytic enzymes
03/19/1998WO1998011233A1 Novel human phosphorylase kinase gamma subunit
03/19/1998WO1998011228A2 Genetic control of fruit ripening
03/19/1998WO1998011227A1 Granulocyte chemotactic protein 2 variant
03/19/1998WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
03/19/1998WO1998011214A1 Mammalian and human rec2
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011204A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998WO1998011203A1 Cells having dna insertion mutations which produce altered amounts of a polypeptide
03/19/1998WO1998011202A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998WO1998011139A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010780A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
03/19/1998WO1998010778A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
03/19/1998WO1998010777A1 Nucleosome-based anti-tumor compositions
03/19/1998WO1998010775A1 Composition and method for repairing neurological tissue
03/19/1998CA2265925A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998CA2265913A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998CA2265670A1 Nucleosome-based anti-tumor compositions
03/19/1998CA2265492A1 Mammalian and human rec2
03/19/1998CA2265455A1 Granulocyte chemotactic protein 2 variant
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264563A1 Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
03/19/1998CA2264545A1 Novel human phosphorylase kinase gamma subunit
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262505A1 Genetic control of fruit ripening
03/18/1998EP0829539A2 Cytoplasmic male sterility dna factor and utilization thereof
03/18/1998EP0828843A1 Recombinant heregulins and their biological functions upon receptor activation
03/18/1998EP0828839A1 Animal gene therapy
03/18/1998EP0828837A2 Dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides
03/18/1998EP0828835A1 HIGH THREONINE DERIVATIVES OF $g(a)-HORDOTHIONIN
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828829A1 A gene switch comprising an ecdysone receptor
03/18/1998EP0828828A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
03/18/1998EP0828826A1 Plant promoter activated by fungal infection
03/18/1998EP0828821A1 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
03/18/1998EP0828820A1 Compositions and methods to prevent microbial contamination of plant tissue culture media
03/18/1998EP0828518A1 Gene transfer for treating a connective tissue of a mammalian host
03/18/1998EP0535148B1 Stimulation of bone marrow stromal and progenitor cells
03/18/1998CN1176659A A method for making heteromultimeric polypeptides
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176391A Monoclonal antibodies against human interleukin-4 and hybridowas producing the same
03/17/1998US5728925 Chimaeric gene coding for a transit peptide and a heterologous polypeptide
03/17/1998US5728915 Transgenic mice which express simian SV 40 T-antigen under control of the retinoblastoma gene promoter
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728814 Monoclonal antibodies, hybridoma cell line
03/17/1998US5728808 Human Prostaglandin receptor IP
03/17/1998US5728806 TIH1, protein that interacts with casein kinase I
03/17/1998US5728803 Pantropic neurotrophic factors
03/17/1998US5728679 BMP-15 compositions
03/17/1998US5728674 Polypeptides as anticoagulants
03/17/1998US5728581 Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
03/17/1998US5728580 Methods and culture media for inducing single cell suspension in insect cell lines
03/17/1998US5728570 Caffeoyl-CoA 3-O-methyltransferase genes
03/17/1998US5728567 Tissue plasminogen activator having zymogenic or fibrin specific properties
03/17/1998US5728561 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from Streptomyces avermitilis
03/17/1998US5728549 Gene expression vectors with controlling sequences of dna
03/17/1998US5728541 Screening therapeutic or chemotherapeutic agents for efficacy as to a specific patient
03/17/1998US5728536 Jak kinases and regulation of Cytokine signal transduction
03/17/1998US5728534 Screening assays involving effect of candidate agent on cell proliferation/activation and on expression of gene responsive to estrogen
03/17/1998US5728520 Immunoreactive polypeptide compositions
03/17/1998US5728388 Contacting sample comprising tumor-sensitized cells with superantigens to produce stimulated cells, infusing into tumor bearing host
03/17/1998US5728381 Diagnosis and treatment of hunter syndrome
03/17/1998US5728379 Tumor- or cell-specific herpes simplex virus replication
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection
03/13/1998CA2215084A1 Cytoplasmic male sterility dna factor and utilization thereof
03/12/1998WO1998010291A1 Biochemical markers of the human endometrium
03/12/1998WO1998010284A1 Purification of antigen-specific t cells
03/12/1998WO1998010092A1 Assessment of intracellular cysteine and glutathione concentrations
03/12/1998WO1998010088A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
1 ... 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 ... 1827